Li Z, Li Z, Peng Y, Zhang M, Wen Y, Lu X
Commun Biol. 2025; 8(1):342.
PMID: 40025288
PMC: 11873049.
DOI: 10.1038/s42003-025-07748-y.
Khachab Y, Hodroj M, Sokhn E
Heliyon. 2025; 11(3):e42419.
PMID: 39981361
PMC: 11840496.
DOI: 10.1016/j.heliyon.2025.e42419.
Walana W, Vicar E, Kuugbee E, Sakida F, Yabasin I, Faakuu E
Front Antibiot. 2025; 2():1291046.
PMID: 39816651
PMC: 11731783.
DOI: 10.3389/frabi.2023.1291046.
Epchtien R, Temkin E, Lurie-Weinberger M, Kastel O, Keren-Paz A, Schwartz D
Microbiol Spectr. 2025; 13(2):e0207924.
PMID: 39807863
PMC: 11792496.
DOI: 10.1128/spectrum.02079-24.
Braun S, Rezk S, Brandt C, Reinicke M, Diezel C, Muller E
Antibiotics (Basel). 2025; 13(12.
PMID: 39766575
PMC: 11672413.
DOI: 10.3390/antibiotics13121185.
Intestinal Colonization of Multidrug-Resistant Organisms: Identification and Antibiotic Susceptibility Patterns of Bacteria Isolated From Healthy Human Fecal Specimens.
Waddepally V, Rabye S, Bashir R, Kandi V
Cureus. 2025; 16(12):e75006.
PMID: 39749090
PMC: 11694048.
DOI: 10.7759/cureus.75006.
Aerobic bacteria study, clinical spectrum, and outcome of patients with community-acquired multidrug-resistant pathogens.
Talari Sree C, Calerappa R, Anke G
J Family Med Prim Care. 2024; 13(11):5052-5059.
PMID: 39723002
PMC: 11668408.
DOI: 10.4103/jfmpc.jfmpc_680_24.
Population-Based Study of Emergence and Spread of Escherichia coli Producing OXA-48-Like Carbapenemases, Israel, 2007-2023.
Temkin E, Bechor M, Lurie-Weinberger M, Keren-Paz A, Chen D, Lugassy C
Emerg Infect Dis. 2024; 31(1):66-74.
PMID: 39714269
PMC: 11682801.
DOI: 10.3201/eid3101.240722.
Cationic conjugated polymers with tunable hydrophobicity for efficient treatment of multidrug-resistant wound biofilm infections.
Nabawy A, Chattopadhyay A, Makabenta J, Hassan M, Yang J, Park J
Biomaterials. 2024; 316():123015.
PMID: 39705926
PMC: 11755787.
DOI: 10.1016/j.biomaterials.2024.123015.
Quaternized Curcumin Derivative-Synthesis, Physicochemical Characteristics, and Photocytotoxicity, Including Antibacterial Activity after Irradiation with Blue Light.
Bakun P, Wysocki M, Stachowiak M, Musielak M, Dlugaszewska J, Mlynarczyk D
Molecules. 2024; 29(19).
PMID: 39407467
PMC: 11478334.
DOI: 10.3390/molecules29194536.
Retrospective Analysis of Antimicrobial Resistance Trends in Pseudomonas aeruginosa and Acinetobacter baumannii.
Ravella Venkatasubramanyam N, Easwaran S, Prabhakaran N
Cureus. 2024; 16(9):e69166.
PMID: 39398730
PMC: 11469660.
DOI: 10.7759/cureus.69166.
Gut resistome of NSCLC patients treated with immunotherapy.
Iwan E, Grenda A, Bomba A, Bielinska K, Wasyl D, Kieszko R
Front Genet. 2024; 15:1378900.
PMID: 39170692
PMC: 11335565.
DOI: 10.3389/fgene.2024.1378900.
Significance of Ongoing Training and Professional Development in Optimizing Healthcare-associated Infection Prevention and Control.
Zhang M, Wu S, Ibrahim M, Md Noor S, Wan Mohammad W
J Med Signals Sens. 2024; 14:13.
PMID: 39100741
PMC: 11296567.
DOI: 10.4103/jmss.jmss_37_23.
Melittin alcalase-hydrolysate: a novel chemically characterized multifunctional bioagent; antibacterial, anti-biofilm and anticancer.
El-Didamony S, Kalaba M, Sharaf M, El-Fakharany E, Osman A, Sitohy M
Front Microbiol. 2024; 15:1419917.
PMID: 39091304
PMC: 11293514.
DOI: 10.3389/fmicb.2024.1419917.
Antibacterial Effect of Silver Nanoparticles against Oral Biofilms in Subjects with Motor and Intellectual Disabilities.
Holguin-Meraz C, Martinez-Martinez R, Zaragoza-Contreras E, Dominguez-Perez R, Reyes-Lopez S, Donohue-Cornejo A
J Funct Biomater. 2024; 15(7).
PMID: 39057312
PMC: 11277624.
DOI: 10.3390/jfb15070191.
New 3-Hydroxypyridine-4-one Analogues: Their Synthesis, Antimicrobial Evaluation, Molecular Docking, and ADME Prediction.
Sadeghian S, Zare F, Saghaie L, Fassihi A, Zare P, Sabet R
Med Chem. 2024; 20(9):900-911.
PMID: 38840401
DOI: 10.2174/0115734064307744240523112710.
Natural Phytochemical and Visible Light at Different Wavelengths Show Synergistic Antibacterial Activity against .
Jeong J, Hwang Y
Pharmaceutics. 2024; 16(5).
PMID: 38794274
PMC: 11125442.
DOI: 10.3390/pharmaceutics16050612.
Bacteriophage therapy in musculoskeletal infections: from basic science to clinical application.
Ferry T, Onsea J, Roussel-Gaillard T, Batailler C, Moriarty T, Metsemakers W
EFORT Open Rev. 2024; 9(5):339-348.
PMID: 38726986
PMC: 11099583.
DOI: 10.1530/EOR-24-0042.
Nanomedicine: Patuletin-conjugated with zinc oxide exhibit potent effects against Gram-negative and Gram-positive bacterial pathogens.
Khan N, Alvi A, Alqassim S, Akbar N, Khatoon B, Kawish M
Biometals. 2024; 37(5):1113-1125.
PMID: 38705945
DOI: 10.1007/s10534-024-00595-0.
A case-control study of the clinical and economic impact of infections caused by Carbapenemase-producing Enterobacterales (CPE).
Montesinos I, Carot-Coll A, Montero M, Sorli Redo L, Siverio-Pares A, Esteban-Cuco S
Infection. 2024; 52(6):2241-2252.
PMID: 38700659
PMC: 11621180.
DOI: 10.1007/s15010-024-02268-z.